Melanotan-1 · Research brief
How Many Doses Vial Melanotan-1? (Storage & Dilution Guide)
Short answer
A single 10mg vial of Melanotan-1 doesn't deliver a predetermined number of doses. The yield depends entirely on how you reconstitute it and what dosage your research protocol requires. Reconstitute a 10mg vial with 2mL of bacteriostatic water and you've created a solution where each 0.1mL contains 500mcg. That same vial reconstituted with 5mL yields 200mcg per 0.1mL.
Key takeaways
- A 10mg Melanotan-1 vial yields 10–20 research doses depending on protocol dosage requirements (1mg vs 500mcg per administration).
- Reconstitution with 2–3mL bacteriostatic water creates concentrations that allow precise measurement of 500mcg–1mg doses using standard insulin syringes.
- Lyophilised Melanotan-1 remains stable at −20°C for 24–36 months, but reconstituted solutions must be refrigerated at 2–8°C and used within 28 days.
- Dose calculation formula: total peptide mass (10mg or 10,000mcg) ÷ target dose per administration = total doses available per vial.
- Bacteriostatic water (0.9% benzyl alcohol) is required for multi-dose vials. Sterile water without preservative loses contamination protection after the first puncture.
A single 10mg vial of Melanotan-1 doesn't deliver a predetermined number of doses. The yield depends entirely on how you reconstitute it and what dosage your research protocol requires. Reconstitute a 10mg vial with 2mL of bacteriostatic water and you've created a solution where each 0.1mL contains 500mcg. That same vial reconstituted with 5mL yields 200mcg per 0.1mL. The dose count isn't written on the vial. It's determined by your dilution math and protocol design.
Our team has guided hundreds of research labs through peptide reconstitution protocols. The gap between doing it right and doing it wrong comes down to three things most suppliers never mention: precise volumetric measurement, sterile reconstitution technique, and proper post-reconstitution storage. Get any one wrong and you've compromised peptide stability before the first research administration.
How many doses are in a 10mg Melanotan-1 vial?
A 10mg Melanotan-1 vial reconstituted with 2mL bacteriostatic water yields 10–20 research doses depending on protocol dosage (500mcg to 1mg per dose). The vial contains 10,000mcg total. Divide by your target dose to calculate exact yield. Proper reconstitution and refrigerated storage at 2–8°C maintains peptide integrity for 28 days post-mixing.
Understanding Melanotan-1 Vial Specifications
Melanotan-1 (afamelanotide) is supplied as lyophilised powder in sealed vials. Typically 10mg per vial for research applications. The lyophilised form remains stable at −20°C for 24–36 months, but once reconstituted with bacteriostatic water, the peptide solution must be refrigerated and used within 28 days. This 28-day window isn't arbitrary. It reflects the degradation rate of the peptide structure in aqueous solution even under optimal refrigeration.
The molecular weight of Melanotan-1 is 1646.85 g/mol, and its mechanism centres on melanocortin receptor binding. Specifically MC1R activation, which drives melanogenesis in melanocytes. Research protocols examining photoprotection or pigmentation response typically use dosages ranging from 250mcg to 1mg per administration depending on the model system and study design. A 10mg vial doesn't dictate dose count. Your protocol's required concentration determines how many research administrations that vial supports.
We've found that labs ordering Melanotan-1 for the first time consistently underestimate the importance of dilution planning. The concentration you create during reconstitution determines whether you can accurately measure small-volume doses or whether you're forced into impractically large injection volumes. Reconstitute 10mg into 1mL and you've created a 10mg/mL solution. Potent, but measuring a 250mcg dose requires withdrawing only 0.025mL, a volume nearly impossible to measure accurately with standard insulin syringes. Reconstitute that same vial into 5mL and the 250mcg dose becomes a manageable 0.125mL.
Calculating Doses from a 10mg Melanotan-1 Vial
Dose calculation follows a simple formula: total peptide mass (mg) ÷ target dose per administration (mg) = total doses per vial. A 10mg vial divided by a 500mcg (0.5mg) dose yields 20 doses. That same vial divided by a 1mg dose yields 10 doses. The math is straightforward. But only if you've reconstituted the vial to a concentration that allows precise volumetric measurement of your target dose.
Most research protocols using Melanotan-1 fall into three dosage tiers: low-dose exploratory studies (250–500mcg per administration), standard photoprotection research (500mcg–1mg), and high-dose melanogenesis observation (1–2mg). Each tier demands a different reconstitution strategy. For 250mcg dosing, reconstitute 10mg into 4–5mL bacteriostatic water to create a 2mg/mL or 2.5mg/mL solution. This makes each 0.1mL equal to 200–250mcg, a volume easily measured with a 1mL insulin syringe marked in 0.01mL increments.
Here's what we've learned guiding labs through dilution planning: if your target dose requires measuring less than 0.05mL per administration, you've over-concentrated your solution. Insulin syringes lose accuracy below 0.05mL due to dead space in the needle hub and plunger tolerances. Reconstitute to a concentration where your target dose falls between 0.1mL and 0.3mL. This range balances measurement precision with reasonable injection volumes for subcutaneous administration in research models.
Melanotan-1 Reconstitution: Dilution Ratios and Concentration
Reconstitution transforms lyophilised Melanotan-1 into a stable aqueous solution, but the concentration you create determines usability. The standard dilution ratios and their resulting concentrations:
| Bacteriostatic Water Volume | Final Concentration | 500mcg Dose Volume | 1mg Dose Volume | Dose Yield (500mcg protocol) | Dose Yield (1mg protocol) |
|---|---|---|---|---|---|
| 1mL | 10mg/mL | 0.05mL | 0.1mL | 20 doses | 10 doses |
| 2mL | 5mg/mL | 0.1mL | 0.2mL | 20 doses | 10 doses |
| 3mL | 3.33mg/mL | 0.15mL | 0.3mL | 20 doses | 10 doses |
| 5mL | 2mg/mL | 0.25mL | 0.5mL | 20 doses | 10 doses |
Bacteriostatic water contains 0.9% benzyl alcohol as a preservative, which inhibits bacterial growth in the reconstituted solution for up to 28 days under refrigeration. Standard bacteriostatic water for injection (USP) is the required diluent. Never use sterile water without preservative, as it offers no contamination protection once the vial seal is punctured multiple times during dose withdrawals. Sterile water reconstitutions must be used within 24 hours or discarded.
Reconstitution technique matters as much as dilution ratio. Inject bacteriostatic water slowly down the inside wall of the vial. Never aim the stream directly at the lyophilised powder. Direct injection creates turbulence that can denature peptide bonds through mechanical stress. Once the water is added, swirl the vial gently in a circular motion until the powder fully dissolves. Typically 30–60 seconds. Never shake the vial. Shaking introduces air bubbles that increase oxidative degradation and create foam that makes accurate dose measurement impossible.
Melanotan-1 Vial Comparison: Concentration vs Usability
Choosing the right dilution ratio balances concentration potency with practical measurement precision. The comparison below maps dilution strategies to research protocol needs:
| Dilution Ratio | Best For | Measurement Precision | Doses Per Vial (500mcg) | Storage Stability | Professional Assessment |
|---|---|---|---|---|---|
| 10mg in 1mL | High-dose protocols (1–2mg) requiring minimal injection volume | Difficult. Requires measuring 0.05–0.1mL accurately | 10–20 | 28 days refrigerated | Over-concentrated for most research applications. Measurement errors likely |
| 10mg in 2mL | Standard research protocols (500mcg–1mg per dose) | Good. 0.1–0.2mL per dose falls within insulin syringe accuracy range | 10–20 | 28 days refrigerated | Optimal balance of concentration and measurement precision for most labs |
| 10mg in 3mL | Low-dose exploratory studies (250–500mcg per dose) | Excellent. Larger volumes reduce measurement error | 20–40 | 28 days refrigerated | Best for protocols requiring frequent small-dose administrations |
| 10mg in 5mL | Very low-dose titration studies (<250mcg per dose) | Excellent. Volumes easily measured with standard syringes | 40+ | 28 days refrigerated | Dilute concentration increases total injection volume. Assess model tolerance |
What If: Melanotan-1 Dosing Scenarios
What If I Reconstitute 10mg Melanotan-1 with 2mL Bacteriostatic Water — How Many 500mcg Doses?
You'll yield exactly 20 doses at 500mcg each. The math: 10mg = 10,000mcg total ÷ 500mcg per dose = 20 doses. With 2mL reconstitution volume, your final concentration is 5mg/mL (or 5000mcg/mL), meaning each 0.1mL contains 500mcg. Withdraw 0.1mL per administration using a 1mL insulin syringe marked in 0.01mL increments. This volume falls within the precision range of standard syringes and minimises measurement error compared to smaller volumes.
What If My Research Protocol Requires 1mg Doses — How Should I Dilute a 10mg Vial?
Reconstitute with 2–3mL bacteriostatic water to create a concentration where 1mg equals 0.2–0.3mL. With 2mL dilution (5mg/mL concentration), each 1mg dose requires withdrawing 0.2mL. A volume easily measured with insulin syringes without dead-space concerns. This yields 10 total doses from the 10mg vial. Avoid 1mL dilution ratios for 1mg dosing. The resulting 0.1mL dose volume approaches the lower accuracy limit of most syringes.
What If I Accidentally Left Reconstituted Melanotan-1 at Room Temperature Overnight?
Discard it. Peptides in aqueous solution undergo accelerated degradation above 8°C. Enzymatic hydrolysis and oxidation compromise tertiary structure within 12–24 hours at room temperature. The solution may appear unchanged (clear, colourless), but peptide potency is unverifiable without HPLC analysis. Temperature excursions above refrigeration range are non-recoverable events. Store reconstituted vials at 2–8°C immediately after mixing and never leave them unrefrigerated for more than 30 minutes during dose preparation.
The Unvarnished Truth About Melanotan-1 Vial Yield
Here's the honest answer: the number printed on the vial (10mg) doesn't tell you how many doses you'll get. Your protocol design does. Labs ordering Melanotan-1 expecting a fixed dose count often discover they've over- or under-diluted only after the first administration when the volume doesn't match their syringe's measurement capability. The peptide supplier can't predetermine your dose count because they don't know whether you're running a 250mcg exploratory study or a 2mg melanogenesis protocol. You determine yield through dilution math before reconstitution. Not by reading the vial label.
The second truth: bacteriostatic water isn't optional for multi-dose vials. Some labs attempt reconstitution with sterile water to avoid benzyl alcohol exposure in their model systems, then store the vial for repeated withdrawals over weeks. This creates contamination risk with every needle puncture. Bacterial growth in peptide solutions stored above 72 hours without preservative is well-documented in compounding literature. If benzyl alcohol is contraindicated for your research model, reconstitute with sterile water but use single-dose aliquoting: immediately after mixing, withdraw the entire solution into multiple sterile syringes (one per planned dose), cap them, and freeze at −20°C. Thaw individual syringes as needed. This preserves sterility without requiring preservatives.
Melanotan-1 Storage and Stability After Reconstitution
Reconstituted Melanotan-1 maintains research-grade potency for 28 days when stored at 2–8°C in its original sealed vial. This 28-day window reflects peptide degradation kinetics in aqueous solution even under optimal conditions. Beyond four weeks, oxidative damage to methionine residues and hydrolysis of peptide bonds reduce melanocortin receptor binding affinity. Light exposure accelerates degradation further: amber glass vials or aluminium foil wrapping block photodegradation of the peptide structure.
Post-reconstitution handling protocol: store the vial upright in the refrigerator main compartment (not the door, where temperature fluctuates with opening/closing). Before each dose withdrawal, allow the vial to reach room temperature for 2–3 minutes. Cold solutions are more viscous and harder to draw accurately. Wipe the rubber stopper with 70% isopropyl alcohol before every needle puncture to prevent contamination. After withdrawing your dose, return the vial to refrigeration immediately.
Freezing reconstituted peptide solutions is not recommended for Melanotan-1. Unlike some peptides that tolerate freeze-thaw cycles, melanocortin receptor agonists show measurable potency loss after freezing due to ice crystal formation disrupting tertiary structure. If you must extend storage beyond 28 days, aliquot the solution into single-dose volumes immediately after reconstitution, freeze those aliquots at −20°C, and thaw each one only once before use. Never refreeze a thawed aliquot.
Our experience shows proper storage and sterile technique matter more than elaborate handling protocols. Research labs running multi-month Melanotan-1 studies consistently report stable results when they follow two rules: refrigerate immediately after every withdrawal, and discard any vial 28 days post-reconstitution regardless of remaining volume. Attempting to extend that window creates result variability that contaminates your data. The cost of a replacement vial is negligible compared to the cost of repeating an entire study phase due to degraded peptide.
You can explore high-purity research peptides like Thymalin and see how precision synthesis extends across our full peptide collection. Every batch undergoes the same small-batch synthesis and amino-acid sequencing verification that guarantees consistency for your research protocols.
If the vial has been stored correctly and you've maintained sterile technique, the 10mg Melanotan-1 vial delivers exactly the dose count your dilution math predicted. If something feels off. Unexpectedly low volume remaining, solution cloudiness, or result inconsistency in your research model. Discard the vial rather than second-guess whether degradation occurred. Peptide research demands absolute confidence in your reagent integrity, and confidence requires following storage protocols without exception.
FAQ
How many doses of Melanotan-1 are in a 10mg vial?
A 10mg vial yields 10–20 research doses depending on your protocol's dosage requirements. If your study uses 500mcg per administration, you'll get 20 doses (10,000mcg ÷ 500mcg = 20). If your protocol requires 1mg per dose, the same vial provides 10 doses. The vial contains a fixed peptide mass. Dose count varies based on how much you administer per research application.
What is the correct way to reconstitute a Melanotan-1 vial for multiple doses?
Inject bacteriostatic water slowly down the inside wall of the vial. Never spray directly onto the lyophilised powder. Add 2–3mL for most research protocols (creating a 3.33–5mg/mL concentration), then swirl gently until fully dissolved. Never shake. Reconstitute with volumes that allow your target dose to fall between 0.1–0.3mL for accurate measurement with standard insulin syringes.
How long does reconstituted Melanotan-1 remain stable in the vial?
Reconstituted Melanotan-1 maintains research-grade potency for 28 days when refrigerated at 2–8°C in a sealed vial with bacteriostatic water. Beyond 28 days, peptide bond hydrolysis and oxidative degradation reduce melanocortin receptor binding affinity even under refrigeration. Discard any reconstituted solution after four weeks regardless of remaining volume. Extending storage introduces result variability.
Can I use sterile water instead of bacteriostatic water to reconstitute Melanotan-1?
Yes, but only if you use the entire reconstituted solution within 24 hours or immediately aliquot it into single-dose syringes and freeze them. Sterile water lacks preservatives, so repeated needle punctures of a multi-dose vial introduce contamination risk. Bacteriostatic water (0.9% benzyl alcohol) inhibits bacterial growth for 28 days and is the standard diluent for research vials requiring multiple withdrawals.
What concentration should I create when reconstituting a 10mg Melanotan-1 vial?
Aim for a concentration where your target dose equals 0.1–0.3mL volume. For 500mcg doses, reconstitute 10mg into 2–3mL (creating 3.33–5mg/mL concentration) so each dose is 0.1–0.15mL. For 1mg doses, use 2–3mL dilution (5mg/mL) so each dose is 0.2mL. Concentrations requiring measurement below 0.05mL per dose are too potent for accurate syringe measurement.
How do I calculate the number of doses in a Melanotan-1 vial?
Divide total peptide mass (in mcg) by your target dose per administration (in mcg). A 10mg vial = 10,000mcg total. For 500mcg doses: 10,000 ÷ 500 = 20 doses. For 1mg (1000mcg) doses: 10,000 ÷ 1000 = 10 doses. The calculation is independent of dilution volume. Reconstitution ratio determines concentration, not total dose count.
What happens if I freeze reconstituted Melanotan-1 solution?
Freezing causes ice crystal formation that disrupts the peptide's tertiary structure, reducing melanocortin receptor binding affinity. If you must freeze reconstituted Melanotan-1, aliquot it into single-dose volumes immediately after mixing, freeze at −20°C, and thaw each aliquot only once before use. Never freeze and thaw the same solution multiple times. Each cycle compounds structural damage.
Can I mix two partially used Melanotan-1 vials together?
No. Combining vials introduces contamination risk and makes it impossible to verify peptide concentration or total remaining mass. Each vial should be tracked individually with reconstitution date and volume recorded on the label. If you have multiple partial vials, use one completely before opening the next. This preserves sterility and allows accurate dose count tracking.
How much bacteriostatic water should I use for a 10mg Melanotan-1 vial?
Use 2–3mL for most research protocols. This creates a 3.33–5mg/mL concentration where typical doses (500mcg–1mg) equal 0.1–0.3mL. Volumes easily measured with insulin syringes. Avoid 1mL dilutions unless your protocol requires 2mg doses, as lower doses would require measuring volumes below 0.1mL where syringe accuracy decreases significantly.
What is the shelf life of lyophilised Melanotan-1 before reconstitution?
Lyophilised Melanotan-1 stored at −20°C remains stable for 24–36 months in sealed vials. The powder form is significantly more stable than reconstituted solutions because water-driven degradation mechanisms (hydrolysis, oxidation) cannot occur in the absence of solvent. Always store unopened vials in a freezer. Room temperature or refrigerator storage reduces shelf life to 6–12 months.
Do I need to refrigerate Melanotan-1 immediately after reconstitution?
Yes. Refrigerate at 2–8°C within 5 minutes of reconstitution. Peptides in aqueous solution begin degrading immediately at room temperature. Enzymatic hydrolysis and oxidation accelerate above 8°C. Even short delays (15–30 minutes at room temperature) before refrigeration measurably reduce peptide potency. Store the vial upright in the main refrigerator compartment, not the door.
How many doses vial Melanotan-1 provides for a 30-day research study?
That depends entirely on your dosing frequency. If your protocol requires one 500mcg dose daily, you'll need 30 doses. Three 10mg vials reconstituted to yield 10 doses each, or two vials reconstituted to yield 15 doses each. If dosing every other day, one 10mg vial (20 doses at 500mcg) covers 40 days. Calculate required vials based on: (daily dose × study duration) ÷ 10,000mcg per vial.
“`
Vial Contents, Label Terminology, and Concentration Math for MT-1
What does the label "melanotan-1 acetate (MT-1) 10 mg/vial" actually describe?
That label describes the total mass of lyophilized powder sealed in the vial, supplied as the acetate salt form of the peptide. Because acetate acts as a counterion, net peptide content sits below the stated salt mass, commonly in the eighty to ninety-five percent range depending on the lot. Independent COAs accompanying each lot report HPLC purity, mass confirmation by MS, and where applicable water and acetate content, allowing laboratories to calculate true peptide mass rather than assuming the label figure represents pure compound.
What information does an MT-1 dosing guide typically cover in a laboratory context?
Such guides function as concentration references rather than clinical instructions. They generally document how much bacteriostatic or sterile diluent is introduced into a 10 mg vial, the resulting concentration expressed as micrograms per unit volume, the number of aliquots obtainable from that volume, and expected stability of the reconstituted solution under refrigeration. Results vary between lots and handling conditions, so laboratories typically verify calculations against the COA net peptide value. Guides of this type describe bench arithmetic only and carry no therapeutic meaning.
What quantities of MT-1 peptide appear in published research literature?
Published pharmacology literature reports MT-1 quantities on a microgram scale in animal models and early human investigations, with considerable variation in study design, and research suggests reported figures are not transferable between models or protocols. No standardized reference quantity exists for non-clinical work, and material supplied here is not an approved drug and is not intended for human or veterinary use. These notes are informational and do not constitute legal advice. Real Peptides supplies melanotan-1 acetate strictly for research use only, with per-lot independent COAs available.
References
Peer-reviewed sources on Melanotan-1 (Afamelanotide) indexed in PubMed, listed for research context. Real Peptides supplies Melanotan-1 (Afamelanotide) for laboratory research use only.
- Afamelanotide in protoporphyria and other skin diseases: a review. Postepy dermatologii i alergologii, 2024. PMID 38784937. doi:10.5114/ada.2024.138818
- Afamelanotide: A Review in Erythropoietic Protoporphyria. American journal of clinical dermatology, 2016. PMID 26979527. doi:10.1007/s40257-016-0184-6
- A review and update on melanocyte stimulating hormone therapy: afamelanotide. Journal of drugs in dermatology : JDD, 2013. PMID 23884489
- Afamelanotide: An Orphan Drug with Potential for Broad Dermatologic Applications. Journal of drugs in dermatology : JDD, 2021. PMID 33683075. doi:10.36849/JDD.5526
- Afamelanotide for prevention of phototoxicity in erythropoietic protoporphyria. Expert review of clinical pharmacology, 2021. PMID 33507118. doi:10.1080/17512433.2021.1879638
- Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders. Clinical pharmacokinetics, 2017. PMID 28063031. doi:10.1007/s40262-016-0501-5
- Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyria. Expert review of clinical pharmacology, 2015. PMID 25470471. doi:10.1586/17512433.2014.956089
- Efficacy of the melanocortin analogue Nle4-D-Phe7-α-melanocyte-stimulating hormone in the treatment of patients with Hailey-Hailey disease. Clinical and experimental dermatology, 2014. PMID 24256215. doi:10.1111/ced.12203
Build a pack
Researching more than one compound?
Build a multi-vial pack and the discount applies automatically as you add doses.
Questions
RESEARCH USE ONLY · NOT EVALUATED BY THE FDA